Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/28/2023 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 25k | $0.36 | $8.9k | | 06/28/2023 |
06/07/2023 | Milestone Pharmaceuticals Inc. | MIST | Grant | Stock Option (right to buy) | 30k | $3.86 | $115.8k | | 06/07/2023 |
01/25/2023 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 25k | $7.80 | $195k | | 01/25/2023 |
07/05/2022 | Milestone Pharmaceuticals Inc. | MIST | Grant | Stock Option (right to buy) | 30k | $6.07 | $182.1k | | 07/05/2022 |
06/16/2022 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 25k | $1.08 | $27k | | 06/16/2022 |
01/25/2022 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 67k | $2.94 | $197k | | 01/25/2022 |
06/14/2021 | Milestone Pharmaceuticals Inc. | MIST | Grant | Stock Option (right to buy) | 30k | $5.54 | $166.2k | | 06/14/2021 |
05/25/2021 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 25k | $5.14 | $128.5k | | 05/25/2021 |
01/26/2021 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 32k | $5.78 | $185k | | 01/26/2021 |
10/01/2020 | Milestone Pharmaceuticals Inc. | MIST | Grant | Stock Option (right to buy) | 30k | $7.10 | $213k | | 10/01/2020 |
06/11/2020 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 15k | $2.94 | $44.1k | | 06/11/2020 |
06/11/2020 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 15k | $2.94 | $44.1k | | 06/11/2020 |
05/15/2020 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (Right to Buy) | 49.2k | $4.05 | $199.4k | | 05/15/2020 |
09/12/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Options | 30k | $5.76 | $172.8k | | 09/12/2019 |
09/12/2019 | Oncternal Therapeutics, Inc. | GTXI | Grant | Stock Option | 30k | $5.76 | $172.8k | | 09/12/2019 |
01/29/2019 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 27.7k | $8.43 | $233.6k | | 01/29/2019 |
06/26/2018 | Oncternal Therapeutics, Inc. | GTXI | Purchase | Common Stock | 5k | $16.75 | $83.8k | | 06/26/2018 |
01/24/2018 | CymaBay Therapeutics, Inc. | CBAY | Grant | Stock Option (right to buy) | 16k | $11.69 | $187k | | 01/24/2018 |
01/01/2018 | Oncternal Therapeutics, Inc. | GTXI | Grant | Employee Stock Option (Right to Buy) | 65k | $12.71 | $826.2k | | 01/01/2018 |
02/28/2017 | Oncternal Therapeutics, Inc. | GTXI | Grant | Employee Stock Option (Right to Buy) | 95k | $4.71 | $447.4k | | 02/28/2017 |